StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech, healthcare · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | LLY Eli Lilly | $1105.00 | -1.93% | $1.04T | 41.2 | 14.4 | +47.4% | 82.8% | 60 |
| 1 | BMY Bristol-Myers Squibb | $57.18 | +0.47% | $116.8B | 19.5 | 2.4 | +1.8% | 53.7% | 73 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $26.18 |
| +0.15% |
| $149.2B |
| 19.9 |
| 2.4 |
| +1.4% |
| 74.8% |
| 67 |
| 3 | JNJ Johnson & Johnson | $225.33 | -2.37% | $542.4B | 25.8 | 5.6 | +7.9% | 68.0% | 66 |
| 4 | MRK Merck | $118.72 | -0.98% | $293.2B | 32.8 | 4.5 | +2.9% | 78.1% | 65 |
| 5 | ZTS Zoetis | $77.69 | -0.74% | $32.8B | 12.4 | 3.4 | +2.4% | 71.8% | 60 |
| 6 | VTRS Viatris | $16.26 | +0.93% | $18.3B | — | 1.3 | +1.6% | 39.8% | 59 |
| 7 | AXSM Axsome Therapeutics | $234.48 | +0.71% | $12.1B | — | 17.0 | +63.9% | 92.6% | 39 |
| 8 | RPRX RPRX | $55.76 | +2.35% | $32.1B | 38.8 | 13.2 | +7.8% | — | — |
| 9 | ELAN ELAN | $23.85 | -0.54% | $11.9B | — | 2.4 | +10.5% | 55.1% | — |